Share
Bacteriophage therapy for Enterococcus faecalis organism
Ajaykumar Oli
(Author)
·
Chandrankanth Kelmani
(Author)
·
LAP Lambert Academic Publishing
· Paperback
Bacteriophage therapy for Enterococcus faecalis organism - Oli, Ajaykumar ; Kelmani, Chandrankanth
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Monday, August 05 and
Thursday, August 15.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Bacteriophage therapy for Enterococcus faecalis organism"
The study revealed the prevalence of multidrug-resistant strains of E.faecalis. Presently, the problem of vancomycin- resistant enterococci (VRE) may not be very high in India as seen in our clinical isolates. The potential of phage has been the subject of several recent reviews and the present study strengthens the view that phage therapy is worth exploring. We resolute our efforts on MDR VRE because we predicted that positive results would reveal the prospective of this form of therapy in situations where few substitutes and alternatives are available. The present investigation is an attempt made to develop an alternative to conventional drugs. One possible option is to use bacteriophage as an antimicrobial agent. Their use as an agents of sanitation or disinfectants for application in controlling clinical and nosocomial infections. The significance of our study is the dose of 3x1010 PFU/ml showed in the increased efficiency of the phage GACP against VREF122 even though having smaller genome.Hence, we conclude that, our phage GACP showed more efficient than earlier reports
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
